Ultrasensitive platform detects Alzheimer’s biomarkers in body fluids with high precision

The Korea Research Institute of Standards and Science (KRISS) has developed a diagnostic platform that amplifies the unique optical signals of molecules by more than a hundred million times, enabling the precise detection and quantification of trace amounts of Alzheimer’s disease biomarkers in body fluids.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup